These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32705228)
1. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters. Qiu F; Chen J; Cao J; Diao F; Huang P Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228 [TBL] [Abstract][Full Text] [Related]
2. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. Cui J; Guo Y; Wu H; Xiong J; Peng T Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427 [TBL] [Abstract][Full Text] [Related]
3. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy. Song J; Xu J; Guo J; Shang Y; Wang J; Wang T Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437 [TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway. Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183 [TBL] [Abstract][Full Text] [Related]
6. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling. Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403 [TBL] [Abstract][Full Text] [Related]
7. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. Liu J; Huang Y; Liu Y; Chen Y Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis. Tian Z; Tan Y; Lin X; Su M; Pan L; Lin L; Ou G; Chen Y Transl Res; 2023 May; 255():66-76. PubMed ID: 36400307 [TBL] [Abstract][Full Text] [Related]
9. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756 [TBL] [Abstract][Full Text] [Related]
10. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts. Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568 [TBL] [Abstract][Full Text] [Related]
11. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757 [TBL] [Abstract][Full Text] [Related]
12. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Li J; Liang X; Yang X Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480 [TBL] [Abstract][Full Text] [Related]
13. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. Yao J; Qian C Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer. Tian X; Hao K; Qin C; Xie K; Xie X; Yang Y Dig Dis Sci; 2013 Sep; 58(9):2705-12. PubMed ID: 23589145 [TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer. Awasthi N; Kronenberger D; Stefaniak A; Hassan MS; von Holzen U; Schwarz MA; Schwarz RE Cancer Lett; 2019 Sep; 459():41-49. PubMed ID: 31153980 [TBL] [Abstract][Full Text] [Related]
18. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells. Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034 [TBL] [Abstract][Full Text] [Related]
19. Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Xie CK; Liao CY; Lin HY; Wu YD; Lu FC; Huang XX; Wang ZW; Li G; Lin CF; Hu JF; Chen YH; Li QW; Chen LQ; Chen HX; Chen S Mol Cancer; 2024 Sep; 23(1):215. PubMed ID: 39350121 [TBL] [Abstract][Full Text] [Related]
20. Microwave hyperthermia enhances the sensitivity of lung cancer cells to gemcitabine through reactive oxygen species‑induced autophagic death. Yang Y; Yang CL; Zhao ZJ; Zuo XX; Liang TS; Yang Y; Ma SL; Yang DK Oncol Rep; 2019 May; 41(5):3100-3110. PubMed ID: 30976815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]